Nemaura Medical Reports Fiscal First Quarter 2024 Results and Provides Business Update
14 août 2023 08h30 HE
|
Nemaura Medical, Inc
Loughborough, England, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
BiondVax Reports Second Quarter Financial Results and Provides Business Update
11 août 2023 09h00 HE
|
BiondVax Pharmaceuticals Ltd.
JERUSALEM, Aug. 11, 2023 (GLOBE NEWSWIRE) -- via IBN - BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative...
IMUNON Reports Second Quarter 2023 Financial Results and Provides Business Update
10 août 2023 08h00 HE
|
Imunon, Inc.
Advances Non-Viral DNA-Mediated Immunotherapy and Next-Generation Vaccine Programs with Multiple Near-Term Milestones Supported by a Strong Balance Sheet Conference Call Begins Today at...
Synlogic Reports Second Quarter 2023 Financial Results and Provides Business Update
10 août 2023 07h00 HE
|
Synlogic, Inc.
CAMBRIDGE, Mass., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
GeoJunxion NV (ticker: GOJXN.AS) - Operationele Update Boekjaar 2022-2023
27 juil. 2023 02h00 HE
|
GeoJunxion N.V.
GeoJunxion NV (ticker: GOJXN.AS) Operationele Update Boekjaar 2022-2023 Belangrijkste feiten: 42% omzetgroei voor boekjaar 2022/23 vergeleken met dezelfde periode in 2021/22;Netto...
GeoJunxion NV (ticker: GOJXN.AS) - Business Update Full Year 2022-2023
27 juil. 2023 02h00 HE
|
GeoJunxion N.V.
GeoJunxion NV (ticker: GOJXN.AS) Business Update Full Year 2022-2023 Key Facts: 42% revenue growth for the FY 2022/’23 compared to the same period in 2021/22;Net Operational Expenses...
ONWARD présente une mise à jour de son activité au premier trimestre ainsi que les faits marquants depuis le début de l’exercice
16 mai 2023 01h30 HE
|
ONWARD Medical
L’ARC-IM™ Lead implanté pour la première fois chez un humainNouvelle désignation de dispositif révolutionnaire décernée par la FDA américaine pour ARC Therapy™, portant le total à 910 brevets...
ONWARD rapporteert Q1 Business Update en hoogtepunten van het jaar
16 mai 2023 01h30 HE
|
ONWARD Medical
ARC-IM™ afleiding voor het eerst geïmplanteerd bij een mensNieuwe 'Breakthrough Device Designation' toegekend door de Amerikaanse FDA voor ARC Therapy™, waarmee het totaal op 9 komt10 bijkomende...
ONWARD Reports Q1 Business Update and Year-To-Date Highlights
16 mai 2023 01h30 HE
|
ONWARD Medical
First-in-Human Use of the ARC-IM™ LeadNew Breakthrough Device Designation Awarded by the U.S. FDA for ARC Therapy™, Bringing Total to 9 10 Additional Patents Issued, Bringing Total Pending and Issued...
SeaStar Medical Reports First Quarter 2023 Financial Results and Provides a Business Update
15 mai 2023 16h45 HE
|
SeaStar Medical Holding Corporation
DENVER, May 15, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a medical device company developing proprietary solutions to reduce...